Intrinsic Edge Capital Management LLC Haemonetics Corp Transaction History
Intrinsic Edge Capital Management LLC
- $782 Million
- Q3 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 108,594 shares of HAE stock, worth $9.85 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
108,594
Previous 110,000
1.28%
Holding current value
$9.85 Million
Previous $9.1 Million
4.1%
% of portfolio
1.12%
Previous 0.87%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
331Shares Held
54.1MCall Options Held
609KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$541 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$469 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$403 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$381 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$365 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.66B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...